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Abstract
Objective—To compare neurocognitive test performance of children with primary hypertension 
to that of normotensive controls.
Study design—Seventy-five children (10-18 years of age) with newly diagnosed, untreated 
hypertension and 75 frequency matched normotensive controls had baseline neurocognitive testing 
as part of a prospective multicenter study of cognition in primary hypertension. Subjects 
completed tests of general intelligence, attention, memory, executive function, and processing 
speed. Parents completed rating scales of executive function and the Sleep-Related Breathing 
Disorder scale of the Pediatric Sleep Questionnaire (PSQ-SRBD).
Results—Hypertension and control groups did not differ significantly in age, sex, maternal 
education, income, race, ethnicity, obesity, anxiety, depression, cholesterol, glucose, insulin, and 
C-reactive protein. Subjects with hypertension had higher PSQ-SRBD scores (p = 0.04) and 
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triglycerides (p = 0.037). Multivariate analyses showed that hypertension was independently 
associated with worse performance on the Rey Auditory Verbal Learning Test (List A Trial 1, p = 
0.034; List A Total, p = 0.009; Short delay recall, p = 0.013), CogState Groton Maze Learning 
Test delayed recall (p = 0.002), Grooved Pegboard dominant hand (p = 0.045), and Wechsler 
Abbreviated Scales of Intelligence Vocabulary (p = 0.016). Results indicated a significant 
interaction between disordered sleep (PSQ-SRBD score) and hypertension on ratings of executive 
function (p = 0.04), such that hypertension heightened the association between increased 
disordered sleep and worse executive function.
Conclusions—Youth with primary hypertension demonstrated significantly lower performance 
on neurocognitive testing compared with normotensive controls, in particular, on measures of 
memory, attention, and executive functions.
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The prevalence of primary hypertension in children has increased significantly, a public 
health phenomenon that parallels the current childhood obesity epidemic. School screening 
studies show that the prevalence of hypertension is as high as 10% in children who are 
overweight, a remarkably high number given that nearly 20% of adolescents in the United 
States are obese.(1, 2) Studies focusing on the impact of childhood primary hypertension 
during youth have found that youth with hypertension often demonstrate similar target organ 
damage findings as adults, including left ventricular hypertrophy (LVH), increased carotid 
intima-media thickness, and increased arterial stiffness.(3-6) Although hypertension in 
young adults has also been associated with lower scores on tests of cognitive performance 
compared with scores in matched normotensive controls(7-9), there have been only very 
limited assessments of hypertensive target organ effects on the brain in children. Instead, 
older descriptions were limited to gross neurologic events, such as facial palsy, seizure, and 
stroke, in children with malignant hypertension.(10) Other studies provide emerging 
evidence that children with primary hypertension score lower on measures of neurocognition 
compared with normotensive controls, a pattern that is similar to young adults with 
hypertension.(11) These preliminary studies in children, however, have been limited mostly 
to database and single-center studies.(12-14) Further study of neurocognition in children 
with hypertension is needed to determine both the short-term impact of childhood 
hypertension on the child’s brain as well as long-term effects, into adulthood, and to assess 
the degree to which any effects can be minimized or reversed.
We have established a prospective, multicenter study of neurocognition in children with 
primary hypertension.(15) Our specific aims are to compare the performance on 
neurocognitive testing of newly diagnosed, subjects with untreated hypertension to that of 
the performance of matched normotensive controls at baseline, and to evaluate the effect of 
1-year of antihypertensive therapy on neurocognitive test performance. Here, we report the 
results of the baseline comparison of the neurocognitive test performance of subjects with 
hypertension and normotensive controls. Consistent with the emerging pediatric literature 
and the existing adult studies, we hypothesize that children with primary hypertension will 
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show significantly lower neurocognitive functions when compared with a matched control 
group of normotensive, healthy peers, particularly in the area of executive functioning.
Methods
Participating recruitment sites included the University of Rochester, Emory University, 
Maimonides Medical Center, and the University of Texas Medical School at Houston. A 
total of seventy-five newly diagnosed, children aged 10 – 18 years old with untreated 
hypertension, were enrolled through the Pediatric Hypertension Clinics at each site. All 
subjects with hypertension were required to have clinic blood pressure (BP) ≥95th 
percentile(6) and sustained hypertension confirmed by 24-hour ambulatory BP monitoring 
(ABPM). For comparison, 75 normotensive, healthy 10-18 year old children were enrolled 
from participating general pediatrics and family medicine practices. Control subjects were 
required to have clinic BP < 95th percentile and normotension confirmed by ABPM. The 
control group was frequency matched to the group with hypertension for maternal education 
(less than high school, high school, college, beyond college), sex, and proportion with 
obesity (body mass index [BMI] ≥95th percentile). Matching for maternal education and 
obesity was done because both factors are known to have potential influence on cognitive 
outcomes (16, 17), and children with hypertension often are obese. Controls were matched 
to the hypertension subjects for sex because hypertension subjects recruited from patients 
referred for hypertension evaluation are more frequently male.(18) Exclusion criteria 
included being on medication for attention-deficit/hyperactivity disorder (ADHD), the 
presence of a pre- existing learning problem/disability (defined as having an Individual 
Educational Plan or Section 504 Plan at school), any disorder of cognitive impairment, 
history of chelation treatment for elevated lead level, history of chronic disease (known 
renal, cardiovascular, gastrointestinal tract, hepatic, endocrine, or rheumatologic disease), 
pregnancy or breast feeding, previous sleep study diagnosis of obstructive sleep apnea, a 
diagnosis of secondary hypertension, and previous or current treatment with 
antihypertensive medication. Subjects with morbid obesity, a group more likely to have 
unrecognized obstructive sleep apnea, were not excluded. The study was approved by the 
Institutional Review Board of each site, and parental permission obtained, as well as subject 
assent, when appropriate.
Neurocognitive Assessment
Measurements from the baseline neurocognitive assessment were analyzed in this report and 
included both laboratory performance-based measures and behavior rating scales. 
Laboratory measures of executive function included tests of problem solving/planning, set-
shifting, response inhibition, vigilance, and working memory. Behavior ratings of executive 
function included the Behavior Rating Inventory of Executive Function (BRIEF) completed 
by the parent. In addition to measures of executive function, the neurocognitive test battery 
included assessments of verbal learning and memory, attention, fine-motor dexterity, and 
general intellectual functioning. Table I lists the neurocognitive tests along with the primary 
variables for each test and the cognitive domain assessed.
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In addition, mood symptoms were evaluated with the child self-report measures of the 
Multidimensional Anxiety Scale for Children (MASC) and the Child Depression Inventory 
(CDI). Lastly, because daytime sleepiness and sleep disorders are associated with cognitive 
dysfunction as well as obesity, parents completed the Sleep-Related Breathing Disorder 
scale of the Pediatric Sleep Questionnaire (PSQ-SRBD) as an estimate of disordered sleep.
(19, 20) These rating scales were examined to determine the need for covarying these 
variables in the data analyses, because sleep and mood can influence neurocognitive 
function.
Other Measures and Procedures
All subjects underwent ABPM at baseline according to published American Heart 
Association guidelines utilizing the Spacelabs 90217 oscillometric monitor.(21) Blood 
pressure measurements were recorded every 20 minutes for the entire 24-hour period, and 
wake and sleep periods were determined by patient diary. A minimum of 40 total readings 
were required for the study to be considered valid without a minimum number of readings 
per hour requirement. BP load was defined as the percentage of readings above the 95th 
percentile for ambulatory norms in the 24-hr period. Subjects with hypertension were 
required to have sustained ambulatory hypertension, defined as mean wake or sleep systolic 
(SBP) or diastolic (DBP) ≥95th percentile for ambulatory norms. A subject with 
hypertension could also be included if the mean ambulatory BP was < 95th percentile, but 
the subject had both BP load > 25% (ambulatory prehypertension) and left ventricular 
hypertrophy (LVH) on echocardiogram. Control subjects were required to have mean wake 
and sleep SBP and DBP < 95th percentile and 24hr BP load < 25% to be included.(21)
Subjects with hypertension underwent baseline echocardiography, which was read centrally 
at the University of Rochester. Control subjects did not have echocardiography. Left 
ventricular mass indexed to height2.7 was determined by the area-length method according 
to standards published by the American Society of Echocardiography.(22) Left ventricular 
hypertrophy was defined as left ventricular mass index (LVMI) ≥ the 95th percentile for age 
and sex.(23)
Because hyperinsulinemia,(24) hyperlipidemia,(25) and chronic inflammation(26) have been 
associated with cognitive deficits in adults, both hypertension and control subjects had 
baseline central laboratory evaluation including fasting lipid profile, insulin level, glucose, 
and C-reactive protein (CRP). Homeostatic model assessment for insulin resistance 
(HOMA-IR) was calculated as glucose × insulin/405.
Statistical Analyses
Patient characteristics were compared between the group with hypertension and 
normotensive controls using 2-sample t-tests for continuous variables and the Fisher exact 
test for categorical variables. For variables with distributions violating assumptions of 
normality, Wilcoxon rank sum tests were used. Ordinal variables were tested using Cochran 
Mantel Haenszel statistics. Results are reported as mean ± standard deviation (SD), or 
median and interquartile range where appropriate. The association between hypertension and 
neurocognitive measures was evaluated using multivariate mixed-effects regression analyses 
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using SAS Proc Mixed with unstructured covariance matrix for estimation. This statistical 
approach remains unaffected by randomly missing data. For measures with significant 
skewed distribution, such as CogState, Grooved Pegboard, and D-KEFS Tower, generalized 
estimating equations (GEE) were used to compare between subject groups. GEE is a semi-
parametric approach that estimates robust standard errors empirically with fewer 
distributional assumptions while accounting for the within subject correlations at the same 
time. We first evaluated the association between hypertension and the overall composite 
neurocognitive measures. Then, for overall composite neurocognitive measures with 
significant main effects of hypertension on the neurocognitive test results, a separate 
multivariate analysis was performed for each individual subtest included in that overall 
composite neurocognitive measure. The overall neurocognitive measures and the individual 
subtests included in the analyses are listed in Table I. Separate multivariate analyses were 
also performed for the Wechsler Abbreviated Scales of Intelligence (WASI) Full Scale IQ 
and the Parent BRIEF Behavioral Regulation Index (BRI) and Metacognition Index (MI), 
with these summary scores as dependent variables. Covariates for all models included age 
and socioeconomic status (maternal education, household income, race, ethnicity) as well as 
demographic and laboratory variables found to be imbalanced between groups, with p < 
0.15. Demographic variables of interest for this analysis included age in years, sex, maternal 
education (less than high school, high school, college, or beyond college), household annual 
income (< $25,000 ≥ $25,000 to < $75,000, > $75,000), self-reported race (African 
American versus non–African American), self-reported ethnicity (Hispanic versus non-
Hispanic), body mass index (BMI) z-score, obesity (BMI percentile ≥ 95), MASC Total T-
score, CDI Total T-score, and PSQ-SRBD score. We also examined the association of 
severity of hypertension (control vs mild-to-moderate vs severe) on neurocognitive 
measures. Mild-to-moderate hypertension was defined as SBP load ≥ 25% but < 50%, no 
LVH), and severe hypertension was defined as SBP load ≥ 50% and/or the presence of LVH. 
The significance level of the data analysis was set at 0.05. Analyses were performed with 
SAS (version 9.3, SAS Institute Inc; Cary, North Carolina).
Results
Seventy-five subjects with hypertension and 75 normotensive control subjects were enrolled. 
Of the 75 subjects with hypertension, 73 were included by having mean wake or sleep BP 
≥95th percentile for ambulatory norms. Only 2 subjects with hypertension were included 
with the alternate criteria of mean ambulatory BP < 95th percentile but BP load > 25% and 
LVH on echocardiogram. Because the number of subjects with hypertension included under 
the alternate criteria was so small, all 75 hypertension subjects were combined for all 
analyses. Table II shows the comparison of characteristics in subjects with hypertension and 
controls. As expected by the matching criteria, the group with hypertension and 
normotensive controls were similar in sex, maternal education, and percent with obesity. The 
groups were also similar in age, race, ethnicity, household income, and BMI z-score. 
Hypertension and control groups also had similar scores in the MASC and CDI scales, 
indicating similar levels of child-reported anxiety and depression, respectively. In contrast, 
the subjects with hypertension had a higher median PSQ-SRBD score, indicating more 
disordered sleep in the group with hypertension. By design, the groups differed in baseline 
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ABPM measurements. Analysis of laboratory evaluation showed that the groups were 
similar in total cholesterol, LDL-cholesterol, HDL-cholesterol, insulin level, HOMA-IR, 
glucose, and CRP. The group with hypertension had a higher triglyceride level than controls. 
Nine of 75 (12%) subjects with hypertension had LVH. Of the 75 subjects with 
hypertension, 51 (68%) were characterized as having severe hypertension, defined as a SBP 
load ≥ 50% and/or LVH.
Group Differences on Neurocognitive Functioning
The principal findings are shown in Table III, including the unadjusted comparison of test 
scores for subjects with hypertension and controls, and the results of multivariate analyses 
for the individual subtests for composite neurocognitive measures found to show an overall 
main effect for hypertension. Comprehensive results for the composite neurocognitive 
measures not found to show an overall main effect for hypertension are shown in Table IV 
(available at www.jpeds.com). Multivariate analyses showed an overall main effect of 
hypertension on worse neurocognitive test performance for the composite Rey Auditory 
Verbal Learning Test (RAVLT, β = -1.13, β SE = 0.44, p = 0.012), composite CogState 
Groton Maze Learning Test (CogState GMLT, β = 4.2, β SE = 1.96, p = 0.031), and the 
Wechsler Abbreviated Scales of Intelligence Full Scale IQ (WASI FSIQ, β = -4.1, β SE = 
1.97, p = 0.038). In contrast, there was not a significant independent association between 
hypertension and neurocognitive test performance for the composite Conners’ Continuous 
Performance Test-II (CPT-II), Wechsler Intelligence Scale – Fourth edition (WISC-IV) Digit 
Span and Spatial Span, composite Grooved Pegboard, CogState Set Shifting, or the 
composite Delis-Kaplan Executive Function System (D-KEFS) Tower test. To summarize, 
hypertension was associated with worse performances on overall measures of verbal 
(RAVLT) and visual (CogState GMLT) learning and recall, and on a measure of verbal and 
visual reasoning (WASI). Hypertension was not associated with performance on tasks of 
vigilance and visuomotor reaction time (CPT-II), auditory and visual attention and working 
memory (WISC-IV Digit Span; Spatial Span), and tasks of problem solving, planning, and 
set shifting between different problem-solving rules (DKEFS Tower Test; CogState Set 
Shifting).
Given the significance of the overall composite tests for RAVLT, CogState GMLT, and 
WASI FSIQ, separate multivariate analysis was performed for each individual subtest 
included in the overall composite neurocognitive measure. The RAVLT evaluates learning 
and recall for verbal information; subjects are presented with a word list and asked to learn 
and then subsequently recall the list. Independent, unaided recall is evaluated twice, both 
immediately after all learning tasks are completed (Short Delay recall), and again after an 
approximately 20 minute delay during which intervening tasks are presented (Long Delay 
recall). Subsequently, a Recognition task is completed in which subjects must choose the 
initial target words from among a longer list that is presented by the examiner. The 
independent recall tasks (short and long delay) are considered more cognitively demanding 
than the Recognition task, as subjects are required to implement their own strategy to 
retrieve the words from memory, without any prompts or cues from the examiner. For the 
RAVLT, hypertension remained independently associated with worse performance on List A 
Trial 1 (a measure of initial learning and of auditory attention), List A total (a composite 
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measure of total learning across all five learning trials), and List A short delay recall, and 
there was a trend toward worse performance on List A long delay recall (Table III). In 
contrast, there was no difference between the group with hypertension and controls in List A 
Recognition.
For CogState GMLT, hypertension remained independently associated with worse 
performance on the Groton Maze Learning Test Delayed Recall Task. In contrast, there was 
no difference between groups for Groton Maze Learning Test Total Error. For the WASI, 
hypertension was significantly associated with lower scores on Vocabulary, but there was no 
difference between groups for Matrix Reasoning. Although the composite Grooved 
Pegboard measure did not show a significant difference between groups, subjects with 
hypertension performed worse on the Grooved Pegboard dominant hand subtest, indicating 
that subjects with hypertension showed worse fine motor dexterity compared with control 
subjects (Table IV).
Parents completed the Parent BRIEF (ratings of executive function in everyday settings) and 
the PSQ-SRBD (rating of disordered sleep). For the Parent BRIEF, unadjusted analysis 
showed that subjects with hypertension scored significantly higher (worse) than 
normotensive controls on the Behavior Regulation Index (BRI, 50.4 ± 11 vs 45.9 ± 7.6, p = 
0.004), but there was no difference between groups on the Metacognition Index (MI, 50.7 
± 10.3 vs 48.2 ± 8.9, p = 0.12). However, multivariate analysis revealed that the BRI score of 
the group with hypertension was not significantly different from that of control subjects (β = 
1.95, p = 0.19), after adjustment for PSQ-SRBD score (β = 29.9, p < 0.001), age (β = -0.07, 
p = 0.84), maternal education (β = -1.3, p = 0.6), household income (β = -1.1, p = 0.26), race 
(β = -1.9, p = 0.28), ethnicity (β = -0.14, p = 0.94), sex (β = -1.4, p = 0.37) triglyceride (β = 
-0.002, p = 0.85), and glucose (β = -1.3, p = 0.24). Because of the strong influence of PSQ-
SRBD score on BRI score and the higher median PSQ-SRBD score in subjects with 
hypertension compared with control subjects, the potential interaction between PSQ-SRBD 
score and hypertension was examined. Repeat multivariate analysis for BRI, adding an 
interaction term for PSQ-SRBD x hypertension, showed a significant interaction of PSQ-
SRBD and hypertension on BRI score (interaction term, p = 0.04), such that the association 
between increased disordered sleep and worse executive function was more pronounced in 
subjects with hypertension than in normotensive subjects (Figure; available at 
www.jpeds.com).
In order to examine the association between the degree of severity of hypertension and 
cognition, separate analyses were performed for the individual subtests of the RAVLT, 
CogState, and WASI for which hypertension was independently associated with worse 
performance. For these analyses, the hypertension variable was separated into mild-to-
moderate hypertension (SBP load ≥ 25% but < 50%, no LVH) and severe hypertension (SBP 
load ≥ 50% and/or LVH). For the RAVLT and CogState tests, the moderate hypertension 
group scored better than the severe hypertension group, but worse than the control group: 
RAVLT List A Trial 1, moderate hypertension mean difference: -0.39, p = 0.34, severe 
hypertension mean difference: -0.67, p = 0.027; RAVLT List A Total: moderate hypertension 
mean difference: -1.8, p = 0.32, severe hypertension mean difference: -3.8, p = 0.005; 
RAVLT List A short delay recall, moderate hypertension mean difference: - 0.65, p=0.33, 
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severe hypertension mean difference : -1.3, p = 0.007; CogState GMLT delayed recall, 
moderate hypertension mean difference: 1.3, p=0.47, control severe hypertension mean 
difference : 4.4, p < 0.001. In contrast, there was no difference in WASI Vocabulary results 
by severity of hypertension (data not shown).
Discussion
We found that children with newly diagnosed, untreated sustained primary hypertension had 
decreased performance on neurocognitive measures of attention, learning, memory, and fine 
motor dexterity compared with a contemporaneous normotensive control group well 
matched for maternal education, race, ethnicity, age, sex, insulin resistance, inflammation 
(CRP levels), negative affect, and obesity. The differences remained significant after 
adjusting for socioeconomic status, age, and imbalances between groups in sex, parent 
ratings of disordered sleep, triglyceride levels, and glucose levels. Specifically, hypertension 
was independently associated with worse performance on subtests of the Rey Auditory 
Verbal Learning Test and the delayed (visual) recall task of the CogState Groton Maze 
Learning Test, both primarily measures of memory, as well as the Grooved Pegboard 
dominant hand subtest, a measure of manual dexterity. In addition, the hypertension group 
had lower scores on WASI Vocabulary, a finding that is conceptually consistent with the 
increased prevalence of learning disabilities previously described in children with primary 
hypertension.(27) The effect sizes of the group differences were modest, but increased when 
the hypertension group was limited to subjects with severe ambulatory hypertension and/or 
LVH, suggesting a dose effect of hypertension on neurocognitive test performance.
Subjects with hypertension also scored worse on parent ratings of executive function (parent 
BRIEF BRI), but this difference did not persist after adjustment for confounders, a result 
largely attributable to the impact of disordered sleep. Despite excluding children with a 
previous sleep study diagnosis of obstructive sleep apnea, the group with hypertension had 
higher parent ratings of disordered sleep compared with the normotensive group, as 
measured by the PSQ-SRBD scale. Children with primary hypertension have an increased 
prevalence of disordered sleep, an entity itself associated with cognitive problems. 
Therefore, disordered sleep potentially confounds the relation between hypertension and 
cognition. We found that subjects with increased disordered sleep (higher PSQ-SRBD score) 
were more likely to have higher (worse) Parent BRI scores, a finding consistent with 
previous studies showing that disordered sleep is associated with problems with executive 
function, and perhaps reflected in daytime sleepiness.(20) However, we also found a 
significant interaction between hypertension and disordered sleep on Parent BRIEF BRI 
scores, suggesting that children with disordered sleep are more likely to have problems with 
decreased executive functioning skills if they also have hypertension. The Parent BRIEF 
BRI rates behaviors that reflect the child’s ability to control impulses, move freely from one 
situation to another, alter problem-solving strategies, and modulate emotional responses.(28) 
These results underscore the complex inter-relation of the effects of hypertension and 
disordered sleep on cognition, especially on the behavioral manifestations of executive 
function, suggesting the importance of sleep to general regulatory functions in day-to-day 
life.
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Adults with hypertension score lower on neurocognitive testing compared with 
normotensive controls, a finding felt to potentially represent an early manifestation of 
hypertensive target organ damage to the brain.(7, 8, 29) Observations from the literature on 
neurocognitive testing in adults with hypertension provided guidance for the design of the 
current study of cognition in children with hypertension. Reports have shown a more 
pronounced difference in neurocognitive test performance between subjects with 
hypertension and normotensive controls when young adults are studied compared with 
studies of middle-aged or older adults,(8) a finding which lends biological plausibility to the 
presence of a hypertension-cognition link in children and adolescents. Young adults with 
hypertension demonstrate performance deficits most consistently in the domains of learning 
and memory, attention, mental flexibility, abstract reasoning, and fine motor dexterity.(7) 
However, few young adults with hypertension are cognitively impaired. Instead, the effect 
size of the difference in performance on neurocognitive testing between adults with 
hypertension and normotensive groups is often small to medium, and absolute scores fall 
within the broad normal range of the tests(25)—findings mirroring the results of the current 
study. Therefore, the current study was designed to detect relatively small differences 
between groups with emphasis on the domains of memory, attention, and executive function. 
Study strategies have been described(15) and included close matching of the groups for 
characteristics that were likely to influence more strongly neurocognitive test performance 
(i.e. maternal education) and exclusion of subjects with pathologic processes that could 
potentially overshadow the smaller cognitive effects of hypertension (ie, ADHD, learning 
problems/disability, previous sleep study with obstructive sleep apnea) in an effort to isolate 
the effects of hypertension on neurocognitive outcomes.
This multicenter study provides confirmation of previous preliminary, single center and 
database reports that first suggested that children with primary hypertension have 
performance deficits on neurocognitive testing in comparison with a rigorously matched 
normotensive control group. Althogh the cross sectional nature of the current analysis limits 
inference regarding causality between hypertension and the lower neurocognitive test 
performance, the similarity in pattern between our findings and those reported in young 
adults with hypertension, along with the presence of a dose effect of the severity of 
hypertension on the neurocognitive findings, suggests that these findings potentially 
represent early hypertensive target organ damage to the brain. Future results from this study 
on the effects of antihypertensive medication on neurocognitive test performance will 
provide further data to establish whether these effects are causative.
The practical implications of the significantly lower performance on measures of attention, 
memory, and executive functions demonstrated in this study are not known, but our results 
raise both short-term and long-term concerns. The finding of demonstrable differences 
between groups, albeit modest, is striking given that youth with hypertension are at the 
earliest stage of their disease process and given the large number of variables that were 
accounted for, either by matching or statistically in the data analyses. In addition, 
hypertension in youth often clusters with other cardiovascular risk factors that may have 
further negative effects on cognition, including obstructive sleep apnea, metabolic syndrome, 
insulin resistance, hyperlipidemia, and chronic inflammation.(6) Furthermore, minority 
youth are at particular risk of developing hypertension,(30) a group already at risk for 
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academic difficulties. We postulate that together the cognitive effects of these cardiovascular 
risk factors may present challenges to some youth with hypertension, especially in the 
context of the cognitively challenging environment of school.
Longitudinal studies have suggested that hypertension from mid-life onward predicts the 
development of cognitive decline in late life.(31, 32) More recently, investigators of the 
Coronary Artery Risk Development in Young Adults (CARDIA) Study showed that 
longitudinal exposure to systolic hypertension in early adulthood is associated with worse 
mid-life cognitive performance.(33) Subjects with hypertensive (age, 18 – 30 years at 
baseline) with 25 years of follow-up demonstrated worse performance in tests of processing 
speed, executive function, and delayed memory (as assessed by the Rey Auditory Verbal 
Learning Test delayed recall task, the same cognitive task that featured prominently in our 
results). Increased fasting blood sugar and total cholesterol were also predictive of mid-life 
cognitive test performance. The authors suggested that young adults with elevated 
cardiovascular risk factors may be a promising target group for early intervention to lessen 
and/or delay later cognitive decline.(33) Our data suggest that the relation between 
hypertension and decreased cognitive test performance c a n extend even further back in age, 
into adolescence, and suggests the possibility that intervention addressing hypertension and 
other cardiovascular risk factors during youth may represent an early opportunity to impact 
cognitive challenges later in life.
The current study has several limitations. There was no neuroimaging component, so we 
cannot discern the physiologic or anatomic basis for the lower neurocognitive test 
performance in children with hypertension. We excluded children with prehypertension and 
white-coat hypertension, so that we cannot evaluate the potential neurocognitive effects of 
these more mild but higher prevalent forms of elevations in blood pressure. By excluding 
subjects on medication for ADHD and those with a learning disability, we may have 
minimized the difference between groups and lost the opportunity to evaluate the potential 
contribution of hypertension to the development of these more overt learning problems; 
however, we were trying to isolate the effects of hypertension on neurocognition, so we 
purposely excluded such subjects.
In summary, our data on an extremely well characterized group of children and adolescents 
with primary hypertension demonstrated significantly lower performance on neurocognitive 
testing compared with matched normotensive controls. In particular, significant differences 
were identified in measures of memory and attention/executive functions. These results 
suggest that hypertension in youth may have an impact on brain function, and perhaps brain 
development in childhood. Future results from this study will assess the degree to which 
these effects can be minimized or reversed with antihypertensive therapies.
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Figure 1. 
The effect of hypertension on the relationship between PSQ-SRBD score and Parent BRIEF 
BRI T-scores (interaction term, p = 0.04). BRI scores and PSQ-SRBD scores are both 
plotted as continuous variables.
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Table 1
Neurocognitive Test Battery
Overall Composite Neurocognitive Test Primary Measures (Individual subtests 
in the composite measure)
Cognitive Domain
Rey Auditory Verbal Learning Test (RAVLT) List A Trial 1 Attention, learning, and memory
List A Total Learning and memory
List A Short Delay Recall Learning and memory
List A Long Delay Recall Learning and memory
List A Recognition Learning and memory
Conners’ Continuous Performance Test-II (CPT-II) Omission Errors Attention and vigilance
Commission Errors Response inhibitionˆ
Variability Attention
Wechsler Abbreviated Scales of Intelligence (WASI) Vocabulary General intelligence
Matrix Reasoning
Full Scale IQ (FSIQ)
Wechsler Intelligence Scale for Children -4th ed (WISC-
IV)
Digit Span Forward and Backward Working memoryˆ, Attention
Spatial Span Forward and Backward
Delis-Kaplan Executive Function System (DKEFS), 
Tower Test
Total Achievement Planning/Problem Solvingˆ
Mean first move time
Time-per-move ratio
Move accuracy ratio
Rule violation-per-item ratio
Grooved Pegboard Test Time to completion Fine motor dexterity
 Dominant hand
 Non-dominant hand
CogState Groton Maze Learning Task (GMLT) GMLT Total Error Planning/Problem Solvingˆ
GMLT Delayed Recall Memory
CogState Set Shifting Set Shifting Total Eror Set Shiftingˆ
Parent Behavior Rating Inventory of Executive Function 
(BRIEF)
Metacognition Index (MI) Behavioral correlates of executive 
functionˆBehavior Regulation Index (BRI)
ˆ
tasks of executive function
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Table 2
Demographic characteristics of the group with hypertension and normotensive controls
Characteristic Hypertensio n N = 75 Normotensive controls N = 75 P value
Male, % 76 63.5 0.097
Maternal Education, % 0.99
 < High School 13.3 13.3
 High School 40 37.3
 College 38.7 44
 > College 8 5.3
Obese, % 66 72 0.49
BMI z-score 2.07 (1.25, 2.51) 1.98 (1.52, 2.31) 0.39
Age, y 15.1 ± 2.2 15.4 ± 1.9 0.35
African American, % 26 24 0.73
Hispanic, % 14 11 0.51
Household income, % 0.35
 < $25,000 36 21.3
 25,000 to < 75,000 29.3 46.7
 > 75,000 34.7 32
PSQ-SRBD score 0.14 (0.06, 0.35) 0.12 (0.05, 0.23) 0.04
Total cholesterol, mg/dl 159 ± 40 154 ± 29 0.38
LDL cholesterol, mg/dl 91± 29 87 ± 26 0.32
HDL cholesterol, mg/dl 46 ± 12 48 ± 12 0.19
Triglyceride, mg/dl 119 ± 85 94 ± 56 0.037
Glucose, mg/dl 89.9 ± 7.2 91.6 ± 6.5 0.13
Insulin, mlU/L 21.3 ± 14.5 22.9 ± 16 0.53
HOMA-IR 4.79 ± 3.44 5.18 ± 3.8 0.50
CRP, mg/L 0.80 (0.4, 2.8) 1.3 (0.6, 3.8) 0.35
MASC Total T-score 47.1 ± 10 48.1 ± 8.5 0.51
CDI Total T-score 44.2 ± 8.8 44.3 ± 9.5 0.91
24 hr SBP Load, % 56.5 ± 17.6 6.6 ± 6.7 < 0.001
24 hr DBP Load, % 26.5 ± 16.4 5.9 ±5.2 < 0.001
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BMI, Body Mass Index; PSQ-SRBD, Pediatric Sleep Questionnaire, Sleep-Related Breathing Disorder scale; LDL, Low-density lipoprotein;HDL, 
High-density lipoprotein; HOMA, Homeostatic model assessment for insulin resistance; CRP, C-reactive protein; MASC, Multidimensional 
Assessment of Anxiety in Children; CDI, Children’s Depression Inventory; SBP, systolic blood pressure; DBP, diastolic blood pressure. Data 
presented as mean ± SD or median (interquartile range).
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